at Investor's Business Daily (Thu, 6:03PM)
Roche's $44.50/share bid for Illumina (ILMN) is lifting shares of the DNA-tech company and its...
Roche's $44.50/share bid for Illumina (ILMN) is lifting shares of the DNA-tech company and its peers. Illumina +40.6% to $52.99. Pacific Biosciences of California (PACB) +26.6%. Complete Genomics (GNOM) +23.6%. Life Technologies (LIFE) +8.5%.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Wed, 2:35PM)
at Zacks.com (Wed, 9:30AM)
at Zacks.com (Wed, 8:35AM)
at Zacks.com (Fri, 2:00PM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs